{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:18:31Z","timestamp":1787861911634,"version":"build-2784847793"},"reference-count":125,"publisher":"Georg Thieme Verlag KG","issue":"04","funder":[{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid","award":["JP20H04129"],"award-info":[{"award-number":["JP20H04129"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["21fk0210096h0001"],"award-info":[{"award-number":["21fk0210096h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>The excessive accumulation of extracellular matrix proteins results in fibrosis\u2014a condition implicated in several diseased conditions, such as nonalcoholic steatohepatitis, viral hepatitis, and autoimmune hepatitis. Despite its prevalence, direct and effective treatments for fibrosis are lacking, warranting the development of better therapeutic strategies. Accumulating evidence has shown that liver fibrosis\u2014a condition previously considered irreversible\u2014is reversible in specific conditions. Immune cells residing in or infiltrating the liver (e.g., macrophages) are crucial in the pathogenesis of fibrosis. Given this background, the roles and action mechanisms of various immune cells and their subsets in the progression and recovery of liver fibrosis, particularly concerning nonalcoholic steatohepatitis, are discussed in this review. Furthermore, the development of better therapeutic strategies based on stage-specific properties and using advanced techniques as well as the mechanisms underlying recovery are elaborated. In conclusion, we consider the review comprehensively provides the present achievements and future possibilities revolving around fibrosis treatment.<\/jats:p>","DOI":"10.1055\/a-1957-6384","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T22:30:55Z","timestamp":1665268255000},"page":"475-488","source":"Crossref","is-referenced-by-count":20,"title":["Regulation of Progression and Resolution of Liver Fibrosis by Immune Cells"],"prefix":"10.1055","volume":"42","author":[{"given":"Yuzo","family":"Koda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"},{"name":"Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Kanai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"},{"name":"Japan Agency for Medical Research and Development, Japan Agency for Medical Research and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"07","key":"ref1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"T G Cotter","year":"2020","journal-title":"Gastroenterology"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis","volume":"56","author":"R D'Ambrosio","year":"2012","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"P Marcellin","year":"2013","journal-title":"Lancet"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"E Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"07","key":"ref5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"T Huby","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Y Koyama","year":"2017","journal-title":"J Clin Invest"},{"issue":"32","key":"ref7","doi-asserted-by":"crossref","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"K Iwaisako","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"I Mederacke","year":"2013","journal-title":"Nat Commun"},{"issue":"07","key":"ref9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"S L Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"S Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/hep.32336","article-title":"T cells: friends and foes in NASH pathogenesis and hepatocarcinogenesis","volume":"75","author":"P Ramadori","year":"2022","journal-title":"Hepatology"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"J D Browning","year":"2004","journal-title":"J Clin Invest"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"A P Rolo","year":"2012","journal-title":"Free Radic Biol Med"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"B Schnabl","year":"2014","journal-title":"Gastroenterology"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"J Mouries","year":"2019","journal-title":"J Hepatol"},{"issue":"07","key":"ref16","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice","volume":"119","author":"E Seki","year":"2009","journal-title":"J Clin Invest"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.22952","article-title":"CCR2 promotes hepatic fibrosis in mice","volume":"50","author":"E Seki","year":"2009","journal-title":"Hepatology"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"O Krenkel","year":"2018","journal-title":"Hepatology"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/hep.26351","article-title":"C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice","volume":"58","author":"P S Chu","year":"2013","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"35146","DOI":"10.1038\/srep35146","article-title":"Bone marrow-derived macrophages distinct from tissue-resident macrophages play a pivotal role in concanavalin A-induced murine liver injury via CCR9 axis","volume":"6","author":"T Amiya","year":"2016","journal-title":"Sci Rep"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2020.09.033","article-title":"Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis","volume":"74","author":"R Morikawa","year":"2021","journal-title":"J Hepatol"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","article-title":"Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling","volume":"16","author":"K Imajo","year":"2012","journal-title":"Cell Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cellimm.2018.08.006","article-title":"Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release","volume":"332","author":"J Pan","year":"2018","journal-title":"Cell Immunol"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","article-title":"\u03b2-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis","volume":"63","author":"P Kocabayoglu","year":"2015","journal-title":"J Hepatol"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80010-5","article-title":"The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo","volume":"30","author":"C Hellerbrand","year":"1999","journal-title":"J Hepatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"d1720","DOI":"10.2741\/pinzani","article-title":"PDGF and signal transduction in hepatic stellate cells","volume":"7","author":"M Pinzani","year":"2002","journal-title":"Front Biosci"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI117497","article-title":"Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture","volume":"94","author":"L Wong","year":"1994","journal-title":"J Clin Invest"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"E Seki","year":"2007","journal-title":"Nat Med"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update","volume":"48","author":"E Seki","year":"2008","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"P Ramachandran","year":"2019","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2018.01.020","article-title":"Macrophages and lipid metabolism","volume":"330","author":"A Remmerie","year":"2018","journal-title":"Cell Immunol"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver","volume":"53","author":"A Remmerie","year":"2020","journal-title":"Immunity"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis","volume":"52","author":"J S Seidman","year":"2020","journal-title":"Immunity"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"M Dudek","year":"2021","journal-title":"Nature"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41591-021-01344-3","article-title":"XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis","volume":"27","author":"A Deczkowska","year":"2021","journal-title":"Nat Med"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2017.01.008","article-title":"Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis","volume":"66","author":"E C Heier","year":"2017","journal-title":"J Hepatol"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"J S Duffield","year":"2005","journal-title":"J Clin Invest"},{"issue":"06","key":"ref38","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/hep.20452","article-title":"Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice","volume":"40","author":"I Sakaida","year":"2004","journal-title":"Hepatology"},{"issue":"46","key":"ref39","doi-asserted-by":"crossref","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis","volume":"109","author":"P Ramachandran","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"05","key":"ref40","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/j.gastro.2014.01.061","article-title":"Vascular endothelial growth factor promotes fibrosis resolution and repair in mice","volume":"146","author":"L Yang","year":"2014","journal-title":"Gastroenterology"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/hep.27635","article-title":"Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis","volume":"61","author":"C Kantari-Mimoun","year":"2015","journal-title":"Hepatology"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hep.24621","article-title":"Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression","volume":"55","author":"J Jiao","year":"2012","journal-title":"Hepatology"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"J P Pradere","year":"2013","journal-title":"Hepatology"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","article-title":"CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells","volume":"12","author":"Y Koda","year":"2021","journal-title":"Nat Commun"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"V L Gadd","year":"2014","journal-title":"Hepatology"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12013-015-0682-9","article-title":"Neutrophils play a crucial role in the early stage of nonalcoholic steatohepatitis via neutrophil elastase in mice","volume":"73","author":"S Zang","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"V Brinkmann","year":"2004","journal-title":"Science"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"D J van der Windt","year":"2018","journal-title":"Hepatology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fimmu.2019.01582","article-title":"The roles of liver-resident lymphocytes in liver diseases","volume":"10","author":"Y Wang","year":"2019","journal-title":"Front Immunol"},{"issue":"03","key":"ref50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","article-title":"Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes","volume":"127","author":"R Safadi","year":"2004","journal-title":"Gastroenterology"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"M J Wolf","year":"2014","journal-title":"Cancer Cell"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep4.1041","article-title":"Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis","volume":"1","author":"J Bhattacharjee","year":"2017","journal-title":"Hepatol Commun"},{"issue":"30","key":"ref53","doi-asserted-by":"crossref","first-page":"eaau1022","DOI":"10.1126\/sciimmunol.aau1022","article-title":"TRM maintenance is regulated by tissue damage via P2RX7","volume":"3","author":"R Stark","year":"2018","journal-title":"Sci Immunol"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.immuni.2020.06.010","article-title":"Sensing of ATP via the purinergic receptor P2RX7 promotes CD8+ Trm cell generation by enhancing their sensitivity to the cytokine TGF-\u03b2","volume":"53","author":"H Borges da Silva","year":"2020","journal-title":"Immunity"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3389\/fimmu.2018.01580","article-title":"In vivo blockade of murine ARTC2.2 during cell preparation preserves the vitality and function of liver tissue-resident memory T cells","volume":"9","author":"B Rissiek","year":"2018","journal-title":"Front Immunol"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.31739","article-title":"The clinical significance of hepatic CD69+ CD103+ CD8+ resident-memory T cells in autoimmune hepatitis","volume":"74","author":"Z You","year":"2021","journal-title":"Hepatology"},{"issue":"599","key":"ref57","doi-asserted-by":"crossref","first-page":"eabb3107","DOI":"10.1126\/scitranslmed.abb3107","article-title":"A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells","volume":"13","author":"C L Zimmer","year":"2021","journal-title":"Sci Transl Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/j.gastro.2019.01.247","article-title":"CXCR6 inhibits hepatocarcinogenesis by promoting natural killer T- and CD4(+) T-cell-dependent control of senescence","volume":"156","author":"J C Mossanen","year":"2019","journal-title":"Gastroenterology"},{"issue":"07","key":"ref59","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1096\/fj.201802534RR","article-title":"The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis","volume":"33","author":"T Wang","year":"2019","journal-title":"FASEB J"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"S Radaeva","year":"2006","journal-title":"Gastroenterology"},{"issue":"04","key":"ref61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaut.2010.09.003","article-title":"CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation","volume":"35","author":"E Hintermann","year":"2010","journal-title":"J Autoimmun"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","article-title":"Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC","volume":"45","author":"A Melhem","year":"2006","journal-title":"J Hepatol"},{"issue":"06","key":"ref63","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/gutjnl-2011-301400","article-title":"NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis","volume":"61","author":"C Gur","year":"2012","journal-title":"Gut"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s10875-011-9571-1","article-title":"Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis","volume":"31","author":"M E Inzaugarat","year":"2011","journal-title":"J Clin Immunol"},{"issue":"13","key":"ref65","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1016\/j.celrep.2018.12.006","article-title":"OX40 regulates both innate and adaptive immunity and promotes nonalcoholic steatohepatitis","volume":"25","author":"G Sun","year":"2018","journal-title":"Cell Rep"},{"issue":"01","key":"ref66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver","volume":"196","author":"M Rau","year":"2016","journal-title":"J Immunol"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"F Meng","year":"2012","journal-title":"Gastroenterology"},{"issue":"06","key":"ref68","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cmet.2021.04.018","article-title":"PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease","volume":"33","author":"M E Moreno-Fernandez","year":"2021","journal-title":"Cell Metab"},{"issue":"06","key":"ref69","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.celrep.2015.07.014","article-title":"Obesity drives Th17 cell differentiation by inducing the lipid metabolic kinase, ACC1","volume":"12","author":"Y Endo","year":"2015","journal-title":"Cell Rep"},{"issue":"11","key":"ref70","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells","volume":"20","author":"L Berod","year":"2014","journal-title":"Nat Med"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26447","article-title":"Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","author":"J Katt","year":"2013","journal-title":"Hepatology"},{"issue":"04","key":"ref72","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hep.31140","article-title":"Monocytes as potential mediators of pathogen-induced T-helper 17 differentiation in patients with primary sclerosing cholangitis (PSC)","volume":"72","author":"L K Kunzmann","year":"2020","journal-title":"Hepatology"},{"issue":"03","key":"ref73","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/hep.31321","article-title":"Inhibition of sphingosine-1-phosphate-induced Th17 cells ameliorates alcohol-associated steatohepatitis in mice","volume":"73","author":"S Chu","year":"2021","journal-title":"Hepatology"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"N Nakamoto","year":"2019","journal-title":"Nat Microbiol"},{"issue":"06","key":"ref75","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","article-title":"IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice","volume":"134","author":"D Li","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/mi.2015.56","article-title":"A protective role for IL-13 receptor \u03b1 1 in bleomycin-induced pulmonary injury and repair","volume":"9","author":"D Karo-Atar","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"11","key":"ref77","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S2213-2600(21)00167-3","article-title":"Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial","volume":"9","author":"K F Rabe","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/rccm.201704-0784OC","article-title":"A phase 2 randomized controlled study of tralokinumab in subjects with idiopathic pulmonary fibrosis","volume":"197","author":"J M Parker","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cytogfr.2018.07.002","article-title":"Innate lymphoid cells in organ fibrosis","volume":"42","author":"Y Mikami","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"issue":"02","key":"ref80","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"T McHedlidze","year":"2013","journal-title":"Immunity"},{"issue":"30","key":"ref81","doi-asserted-by":"crossref","first-page":"48563","DOI":"10.18632\/oncotarget.18335","article-title":"Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis","volume":"8","author":"P Vasseur","year":"2017","journal-title":"Oncotarget"},{"issue":"396","key":"ref82","doi-asserted-by":"crossref","first-page":"eaal3694","DOI":"10.1126\/scitranslmed.aal3694","article-title":"Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-\u03b2","volume":"9","author":"K M Hart","year":"2017","journal-title":"Sci Transl Med"},{"issue":"07","key":"ref83","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"D A Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","article-title":"T cells in fibrosis and fibrotic diseases","volume":"11","author":"M Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.12659\/MSM.899725","article-title":"Immune regulation of intrahepatic regulatory T cells in fibrotic livers of mice","volume":"23","author":"X Zhang","year":"2017","journal-title":"Med Sci Monit"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.trsl.2015.10.008","article-title":"Persistence of cirrhosis is maintained by intrahepatic regulatory T cells that inhibit fibrosis resolution by regulating the balance of tissue inhibitors of metalloproteinases and matrix metalloproteinases","volume":"169","author":"X Zhang","year":"2016","journal-title":"Transl Res"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3389\/fimmu.2020.01711","article-title":"Adoptive cell transfer of regulatory T cells exacerbates hepatic steatosis in high-fat high-fructose diet-fed mice","volume":"11","author":"M A Van Herck","year":"2020","journal-title":"Front Immunol"},{"issue":"06","key":"ref88","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"H Wang","year":"2021","journal-title":"J Hepatol"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12865-017-0215-y","article-title":"The imbalance of Th17\/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice","volume":"18","author":"B He","year":"2017","journal-title":"BMC Immunol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"584048","DOI":"10.3389\/fimmu.2020.584048","article-title":"Foxp3+ regulatory T cells inhibit CCl4-induced liver inflammation and fibrosis by regulating tissue cellular immunity","volume":"11","author":"Y Ikeno","year":"2020","journal-title":"Front Immunol"},{"issue":"09","key":"ref91","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-021-00519-w","article-title":"Tissue regulatory T cells: regulatory chameleons","volume":"21","author":"A R Mu\u00f1oz-Rojas","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2018.06.015","article-title":"B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)","volume":"124","author":"S Bruzz\u00ec","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"S Shalapour","year":"2017","journal-title":"Nature"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"F Barrow","year":"2021","journal-title":"Hepatology"},{"issue":"05","key":"ref95","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2014.01.010","article-title":"Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease","volume":"60","author":"S McPherson","year":"2014","journal-title":"J Hepatol"},{"issue":"02","key":"ref96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13317-013-0046-7","article-title":"Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis","volume":"4","author":"T Himoto","year":"2013","journal-title":"Auto Immun Highlights"},{"issue":"02","key":"ref97","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.26697","article-title":"Chemokine receptor CCR6-dependent accumulation of \u03b3\u03b4 T cells in injured liver restricts hepatic inflammation and fibrosis","volume":"59","author":"L Hammerich","year":"2014","journal-title":"Hepatology"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2019.00477","article-title":"\u03b3\u03b4T cells suppress liver fibrosis via strong cytolysis and enhanced NK cell-mediated cytotoxicity against hepatic stellate cells","volume":"10","author":"M Liu","year":"2019","journal-title":"Front Immunol"},{"issue":"12","key":"ref99","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41577-020-0345-y","article-title":"Thymic development of unconventional T cells: how NKT cells, MAIT cells and \u03b3\u03b4 T cells emerge","volume":"20","author":"D G Pellicci","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"04","key":"ref100","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells","volume":"117","author":"M Dusseaux","year":"2011","journal-title":"Blood"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-018-04450-y","article-title":"Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver","volume":"9","author":"P Hegde","year":"2018","journal-title":"Nat Commun"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI78941","article-title":"Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients","volume":"125","author":"I Magalhaes","year":"2015","journal-title":"J Clin Invest"},{"issue":"08","key":"ref103","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"M Swiecki","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"08","key":"ref104","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1172\/JCI125863","article-title":"Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35","volume":"129","author":"Y Koda","year":"2019","journal-title":"J Clin Invest"},{"issue":"11","key":"ref105","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ni.1658","article-title":"CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease","volume":"9","author":"H Hadeiba","year":"2008","journal-title":"Nat Immunol"},{"issue":"01","key":"ref106","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.27037","article-title":"Plasmacytoid dendritic cell-derived IFN-\u03b1 promotes murine liver ischemia\/reperfusion injury by induction of hepatocyte IRF-1","volume":"60","author":"A Castellaneta","year":"2014","journal-title":"Hepatology"},{"issue":"03","key":"ref107","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.celrep.2016.06.024","article-title":"Nucleic acid-targeting pathways promote inflammation in obesity-related insulin resistance","volume":"16","author":"X S Revelo","year":"2016","journal-title":"Cell Rep"},{"issue":"05","key":"ref108","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cmet.2016.04.010","article-title":"Indoleamine 2,3-dioxygenase-expressing aortic plasmacytoid dendritic cells protect against atherosclerosis by induction of regulatory T cells","volume":"23","author":"T J Yun","year":"2016","journal-title":"Cell Metab"},{"issue":"17","key":"ref109","doi-asserted-by":"crossref","first-page":"e159910","DOI":"10.1172\/jci.insight.159910","article-title":"CCR9 axis inhibition enhances hepatic migration of plasmacytoid DCs and protects against liver injury","volume":"7","author":"Y Koda","year":"2022","journal-title":"JCI Insight"},{"issue":"10","key":"ref110","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00125-017-4341-0","article-title":"Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice","volume":"60","author":"T D Hannibal","year":"2017","journal-title":"Diabetologia"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fimmu.2020.00931","article-title":"Modulation of inflammation by extracellular granzyme A","volume":"11","author":"K R van Daalen","year":"2020","journal-title":"Front Immunol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.2147\/DDDT.S315724","article-title":"Non-alcoholic steatohepatitis (NASH) - a review of a crowded clinical landscape, driven by a complex disease","volume":"15","author":"J M Fraile","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Z M Younossi","year":"2019","journal-title":"Lancet"},{"issue":"01","key":"ref114","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2020.08.004","article-title":"Efficacy and safety of aldafermin, an engineered FGF19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis","volume":"160","author":"S A Harrison","year":"2021","journal-title":"Gastroenterology"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"A Sanyal","year":"2019","journal-title":"Lancet"},{"issue":"02","key":"ref116","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/metabo11020073","article-title":"Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an updated meta-analysis of randomized controlled trials","volume":"11","author":"A Mantovani","year":"2021","journal-title":"Metabolites"},{"issue":"02","key":"ref117","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/13543784.2020.1668375","article-title":"Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"29","author":"M J Westerouen Van Meeteren","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"issue":"05","key":"ref118","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"S L Friedman","year":"2018","journal-title":"Hepatology"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"S594","DOI":"10.1016\/S0168-8278(17)31616-1","article-title":"Impact of weight reduction on serum markers and liver histology including progression to cirrhosis in patients with nonalcoholic steatohepatitis (NASH) and bridging fibrosis","volume":"66","author":"V Ratziu","year":"2017","journal-title":"J Hepatol"},{"issue":"04","key":"ref120","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.32181","article-title":"BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial","volume":"75","author":"E J Lawitz","year":"2022","journal-title":"Hepatology"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"C Amor","year":"2020","journal-title":"Nature"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"105922","DOI":"10.1016\/j.cct.2019.105922","article-title":"Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design","volume":"89","author":"Q M Anstee","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S0168-8278(18)30425-2","article-title":"JKB-121 in patients with nonalcoholic steatohepatitis: a phase 2 double blind randomized placebo control study","volume":"68","author":"A M Diehl","year":"2018","journal-title":"J Hepatol"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/apt.13816","article-title":"Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis","volume":"44","author":"S A Harrison","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"04","key":"ref125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41565-020-00836-6","article-title":"Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis","volume":"16","author":"M Hu","year":"2021","journal-title":"Nat Nanotechnol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1957-6384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:50:25Z","timestamp":1670028625000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1957-6384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":125,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2022,12,2]]},"published-print":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1957-6384","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,8]]},"published":{"date-parts":[[2022,10,8]]}}}